Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium channels, memory T cells, and multiple sclerosis.

Christine Beeton1, K George Chandy

  • 1Department of Physiology and Biophysics, Medical School, University of California, Irvine, 92697, USA.

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|November 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis.

Current opinion in immunology·2026
Same author

Structural basis for the subtype-selectivity of K<sub>Ca</sub>2.2 channel activators.

Nature communications·2026
Same author

Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats.

Microbial cell factories·2025
Same author

Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel K<sub>Ca</sub>3.1.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Cryo-EM structures of the small-conductance Ca<sup>2+</sup>-activated K<sub>Ca</sub>2.2 channel.

Nature communications·2025
Same author

In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene.

Science translational medicine·2025

Inhibiting the Kv1.3 potassium channel in immune cells offers a promising therapeutic strategy for multiple sclerosis. This approach targets the chronic inflammation and nerve damage characteristic of this autoimmune disease.

Area of Science:

  • Neuroimmunology
  • Ion Channel Physiology

Background:

  • Multiple sclerosis (MS) is an autoimmune disease damaging the central nervous system.
  • Demyelination and axonal damage lead to severe neurological deficits in MS patients.

Purpose of the Study:

  • To present the rationale for using Kv1.3 K+ channel inhibitors as a potential therapy for MS.
  • To explore the application of these inhibitors in treating other autoimmune disorders.

Main Methods:

  • Review of existing research on Kv1.3 channel function in immune cells.
  • Analysis of the role of Kv1.3 channels in autoimmune disease pathogenesis.

Main Results:

  • Kv1.3 channels are crucial for the function of key immune cells involved in MS.

Related Experiment Videos

  • Inhibiting Kv1.3 channels can modulate immune responses implicated in autoimmune diseases.

    • Conclusions:

    • Targeting Kv1.3 K+ channels represents a viable therapeutic avenue for multiple sclerosis.
    • Kv1.3 inhibition holds potential for managing other autoimmune conditions.